CRISPR Therapeutics AG vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 06/27/26
Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained TodayZacks Investment Research • 06/26/26
Vertex Pharmaceuticals: Povetacicept May Redefine Growth Narrative (Rating Upgrade)Seeking Alpha • 06/24/26
Vertex Has a Head Start in Non-Opioid Pain. Eli Lilly Just Spent Billions to Catch Up.The Motley Fool • 06/20/26
The Death Cross Is Lying: Why Wall Street Is Still Loading Up on Hershey and Vertex24/7 Wall Street • 06/12/26
Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5–11, at the European Hematology Association Congress and Announces Additional Global Regulatory SubmissionsBusiness Wire • 06/11/26
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/10/26
Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026?The Motley Fool • 06/08/26
Vertex to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10Business Wire • 06/03/26
Vertex (VRTX) Up 0.2% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/03/26
Got $5,000? 1 Cash-Flow King to Buy and Hold Forever That Wall Street Is Completely Mispricing24/7 Wall Street • 06/02/26
Vertex Stock Down Nearly 8% in 3 Months: Time to Buy or Stay Cautious?Zacks Investment Research • 06/01/26
Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA NephropathyBusiness Wire • 06/01/26
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Bernstein 42nd Annual Strategic Decisions Conference TranscriptSeeking Alpha • 05/29/26
Vertex Pharmaceuticals Incorporated (VRTX) Presents at RBC Capital Markets Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/19/26
VRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 EarningsZacks Investment Research • 05/08/26
Vertex Pharmaceuticals Q1 Earnings Review: Pharma May Need Bolder M&A StrategySeeking Alpha • 05/06/26